BIOMOTCPharmaceutical PreparationsFiscal year ends December 31
BIOMOLECULAR LIFE HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 19, 2015
$0.79−0.02 (-2.47%)
Close on Oct 19, 2026
- Market cap
- $67.51M
- P/E (TTM)
- –
- Dividend yield
- –
Biomolecular Life statistics
Financials through Dec 31, 2014, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Market Cap | $85.23M | $166.30M |
| Enterprise Value | $85.86M | $88.19M |
Income (trailing twelve months)
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Revenue | $0 | $58.34M |
| Operating Income | -$4.14M | -$21.40M |
| Net Income | -$6.19M | -$22.46M |
| EBITDA | -$4.14M | -$16.91M |
| EPS (Diluted) | -$0.22 | -$0.83 |
Returns
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Return on Assets (ROA) | -467.8% | -40.9% |
Balance sheet
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $33.99K | $61.43M |
| Net Cash (Debt) | $33.99K | $15.35M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$4.51M | $49.09M |
| Book Value Per Share | -$0.04 | $1.37 |
| Tangible Book Value | -$5.58M | $23.52M |
| Working Capital | -$5.58M | $76.81M |
Financial position
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Current Ratio | 0.04 | 3.34 |
| Quick Ratio | 0.01 | 2.44 |
| Interest Coverage | -1.50 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Operating Cash Flow | -$1.91M | -$12.35M |
| Capital Expenditures | $0 | -$1.08M |
| Free Cash Flow | -$1.91M | -$20.22M |
| FCF Per Share | -$0.02 | -$0.42 |
Efficiency
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.39 |
| Revenue Per Employee | $0 | $404.87K |
| Profits Per Employee | -$6.19M | -$703.34K |
| Employee Count | 1 | 74 |
Dividends and yields
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Earnings Yield | -7.26% | -23.3% |
| FCF Yield | -2.24% | -8.72% |
Shares
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Shares Outstanding | 107,883,000 | 58,127,000 |
| Float | 107,883,000 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
Taxes
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | Biomolecular Life | Industry median |
|---|---|---|
| Altman Z-Score | -118.75 | -0.22 |
Calculated by StockData from Biomolecular Life's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.